Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 91

1.

MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs.

Gabisonia K, Prosdocimo G, Aquaro GD, Carlucci L, Zentilin L, Secco I, Ali H, Braga L, Gorgodze N, Bernini F, Burchielli S, Collesi C, Zandonà L, Sinagra G, Piacenti M, Zacchigna S, Bussani R, Recchia FA, Giacca M.

Nature. 2019 May;569(7756):418-422. doi: 10.1038/s41586-019-1191-6. Epub 2019 May 8.

PMID:
31068698
2.

Intracoronary Gene Delivery of the Cytoprotective Factor Vascular Endothelial Growth Factor-B167 in Canine Patients with Dilated Cardiomyopathy: A Short-Term Feasibility Study.

Paradies P, Carlucci L, Woitek F, Staffieri F, Lacitignola L, Ceci L, Romano D, Sasanelli M, Zentilin L, Giacca M, Salvadori S, Crovace A, Recchia FA.

Vet Sci. 2019 Mar 6;6(1). pii: E23. doi: 10.3390/vetsci6010023.

3.

The failing heart utilizes 3-hydroxybutyrate as a metabolic stress defense.

Horton JL, Davidson MT, Kurishima C, Vega RB, Powers JC, Matsuura TR, Petucci C, Lewandowski ED, Crawford PA, Muoio DM, Recchia FA, Kelly DP.

JCI Insight. 2019 Feb 21;4(4). pii: 124079. doi: 10.1172/jci.insight.124079. eCollection 2019 Feb 21.

4.

Gene Therapy for Heart Failure: New Perspectives.

Gabisonia K, Recchia FA.

Curr Heart Fail Rep. 2018 Dec;15(6):340-349. doi: 10.1007/s11897-018-0410-z. Review.

PMID:
30238397
5.

Pathogenic role of mitochondrial calcium uniporter upregulation in the failing heart: Ca2+ mishandling or what else?

Recchia FA, Gorgodze N, Gabisonia K.

Int J Cardiol. 2019 Jan 1;274:250-251. doi: 10.1016/j.ijcard.2018.07.007. Epub 2018 Jul 4. No abstract available.

PMID:
30146250
6.

Guidelines for experimental models of myocardial ischemia and infarction.

Lindsey ML, Bolli R, Canty JM Jr, Du XJ, Frangogiannis NG, Frantz S, Gourdie RG, Holmes JW, Jones SP, Kloner RA, Lefer DJ, Liao R, Murphy E, Ping P, Przyklenk K, Recchia FA, Schwartz Longacre L, Ripplinger CM, Van Eyk JE, Heusch G.

Am J Physiol Heart Circ Physiol. 2018 Apr 1;314(4):H812-H838. doi: 10.1152/ajpheart.00335.2017. Epub 2018 Jan 12.

7.

Acute and Chronic Increases of Circulating FSTL1 Normalize Energy Substrate Metabolism in Pacing-Induced Heart Failure.

Seki M, Powers JC, Maruyama S, Zuriaga MA, Wu CL, Kurishima C, Kim L, Johnson J, Poidomani A, Wang T, Muñoz E, Rajan S, Park JY, Walsh K, Recchia FA.

Circ Heart Fail. 2018 Jan;11(1):e004486. doi: 10.1161/CIRCHEARTFAILURE.117.004486.

8.

Combination Cell Therapy for Ischemic Cardiomyopathy: Is the Whole Greater Than Sum of Its Parts?

Recchia FA, Sharp TE 3rd.

J Am Coll Cardiol. 2017 Nov 14;70(20):2516-2518. doi: 10.1016/j.jacc.2017.09.1065. No abstract available.

9.

Why publish in the American Journal of Physiology-Heart and Circulatory Physiology?

Zucker IH, Lindsey ML, Delmar M, De Windt LJ, Des Rosiers C, Diz DI, Hester RL, Jones SP, Kanagy NL, Kitakaze M, Liao R, Lopaschuk GD, Patel KP, Recchia FA, Sadoshima J, Shah AM, Ungvari Z, Benjamin IJ, Blaustein MP, Charkoudian N, Efimov IR, Gutterman D, Kass DA, Liao Y, O'Leary DS, Ripplinger CM, Wolin MS.

Am J Physiol Heart Circ Physiol. 2017 Aug 1;313(2):H221-H223. doi: 10.1152/ajpheart.00329.2017. Epub 2017 Jun 16. No abstract available.

10.

Proteomics-based network analysis characterizes biological processes and pathways activated by preconditioned mesenchymal stem cells in cardiac repair mechanisms.

Di Silvestre D, Brambilla F, Scardoni G, Brunetti P, Motta S, Matteucci M, Laudanna C, Recchia FA, Lionetti V, Mauri P.

Biochim Biophys Acta Gen Subj. 2017 May;1861(5 Pt A):1190-1199. doi: 10.1016/j.bbagen.2017.02.006. Epub 2017 Mar 7.

PMID:
28286014
11.

Analysis of Serum Cholesterol Efflux Capacity in a Minipig Model of Nonischemic Heart Failure.

Bigazzi F, Adorni MP, Puntoni M, Sbrana F, Lionetti V, Pino BD, Favari E, Recchia FA, Bernini F, Sampietro T.

J Atheroscler Thromb. 2017 Aug 1;24(8):853-862. doi: 10.5551/jat.37101. Epub 2016 Dec 15.

12.

Magnetic resonance imaging of infarct-induced canonical wingless/integrated (Wnt)/β-catenin/T-cell factor pathway activation, in vivo.

Matteucci M, Casieri V, Gabisonia K, Aquaro GD, Agostini S, Pollio G, Diamanti D, Rossi M, Travagli M, Porcari V, Recchia FA, Lionetti V.

Cardiovasc Res. 2016 Dec;112(3):645-655. Epub 2016 Sep 26.

13.

Class I Histone Deacetylase Inhibition for the Treatment of Sustained Atrial Fibrillation.

Seki M, LaCanna R, Powers JC, Vrakas C, Liu F, Berretta R, Chacko G, Holten J, Jadiya P, Wang T, Arkles JS, Copper JM, Houser SR, Huang J, Patel VV, Recchia FA.

J Pharmacol Exp Ther. 2016 Sep;358(3):441-9. doi: 10.1124/jpet.116.234591. Epub 2016 Jun 27.

14.

Follistatin-like 1 promotes cardiac fibroblast activation and protects the heart from rupture.

Maruyama S, Nakamura K, Papanicolaou KN, Sano S, Shimizu I, Asaumi Y, van den Hoff MJ, Ouchi N, Recchia FA, Walsh K.

EMBO Mol Med. 2016 Aug 1;8(8):949-66. doi: 10.15252/emmm.201506151. Print 2016 Aug.

15.

Assessing Cardiac Metabolism: A Scientific Statement From the American Heart Association.

Taegtmeyer H, Young ME, Lopaschuk GD, Abel ED, Brunengraber H, Darley-Usmar V, Des Rosiers C, Gerszten R, Glatz JF, Griffin JL, Gropler RJ, Holzhuetter HG, Kizer JR, Lewandowski ED, Malloy CR, Neubauer S, Peterson LR, Portman MA, Recchia FA, Van Eyk JE, Wang TJ; American Heart Association Council on Basic Cardiovascular Sciences.

Circ Res. 2016 May 13;118(10):1659-701. doi: 10.1161/RES.0000000000000097. Epub 2016 Mar 24. Review. Erratum in: Circ Res. 2016 May 13;118(10):e35.

16.

Acetylation mediates Cx43 reduction caused by electrical stimulation.

Meraviglia V, Azzimato V, Colussi C, Florio MC, Binda A, Panariti A, Qanud K, Suffredini S, Gennaccaro L, Miragoli M, Barbuti A, Lampe PD, Gaetano C, Pramstaller PP, Capogrossi MC, Recchia FA, Pompilio G, Rivolta I, Rossini A.

J Mol Cell Cardiol. 2015 Oct;87:54-64. doi: 10.1016/j.yjmcc.2015.08.001. Epub 2015 Aug 8.

17.

Arginine vasopressin receptor signaling and functional outcomes in heart failure.

Wasilewski MA, Myers VD, Recchia FA, Feldman AM, Tilley DG.

Cell Signal. 2016 Mar;28(3):224-233. doi: 10.1016/j.cellsig.2015.07.021. Epub 2015 Jul 30. Review. No abstract available.

18.

Intracoronary Cytoprotective Gene Therapy: A Study of VEGF-B167 in a Pre-Clinical Animal Model of Dilated Cardiomyopathy.

Woitek F, Zentilin L, Hoffman NE, Powers JC, Ottiger I, Parikh S, Kulczycki AM, Hurst M, Ring N, Wang T, Shaikh F, Gross P, Singh H, Kolpakov MA, Linke A, Houser SR, Rizzo V, Sabri A, Madesh M, Giacca M, Recchia FA.

J Am Coll Cardiol. 2015 Jul 14;66(2):139-53. doi: 10.1016/j.jacc.2015.04.071.

19.

Metabolic alterations induce oxidative stress in diabetic and failing hearts: different pathways, same outcome.

Roul D, Recchia FA.

Antioxid Redox Signal. 2015 Jun 10;22(17):1502-14. doi: 10.1089/ars.2015.6311. Epub 2015 Apr 30. Review.

20.

Revascularization of hibernating myocardium: uneven reflorescence after the drought.

Recchia FA.

J Am Coll Cardiol. 2015 Feb 24;65(7):698-700. doi: 10.1016/j.jacc.2014.12.024. No abstract available.

Supplemental Content

Loading ...
Support Center